This topic aims to pool the most recent advances in the phenomenology and pathophysiology of levodopa-induced dyskinesias. The papers in this eBook have strongly contributed to reduce the gaps in our knowledge of LIDs pathogenesis
Levodopa-induced dyskinesias (LID) are common and difficult to treat. This review focuses on three i...
Levodopa remains the primary drug for controlling motor symptoms in Parkinson’s disease through the ...
"Levodopa-induced dyskinesias (LID) are commonly encountered in advanced Parkinson's disease (PD), a...
fter its first use in clinic since 1960, oral administration of l-3,4-dihydroxyphenylalanine (levodo...
Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal mo...
Levodopa-induced dyskinesias (LIDs) occur in the majority of patients with Parkinson's disease (PD) ...
© 2019 International Parkinson and Movement Disorder Society Levodopa-induced dyskinesia (LID) repre...
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) the...
Dystonia and levodopa-induced dyskinesia (LID) are both hyperkinetic movement disorders. Dystonia ar...
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) the...
Copyright © 2012 J. Guridi et al. This is an open access article distributed under the Creative Comm...
Panagiotis Bargiotas, Spyridon KonitsiotisDepartment of Neurology, University of Ioannina, Ioannina,...
The most commonly used treatment for Parkinson’s disease (PD) is levodopa, prescribed in conjunction...
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) the...
Parkinson‘s disease (PD) is a progressive and disabling neurodegenerative disease, characterized by ...
Levodopa-induced dyskinesias (LID) are common and difficult to treat. This review focuses on three i...
Levodopa remains the primary drug for controlling motor symptoms in Parkinson’s disease through the ...
"Levodopa-induced dyskinesias (LID) are commonly encountered in advanced Parkinson's disease (PD), a...
fter its first use in clinic since 1960, oral administration of l-3,4-dihydroxyphenylalanine (levodo...
Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal mo...
Levodopa-induced dyskinesias (LIDs) occur in the majority of patients with Parkinson's disease (PD) ...
© 2019 International Parkinson and Movement Disorder Society Levodopa-induced dyskinesia (LID) repre...
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) the...
Dystonia and levodopa-induced dyskinesia (LID) are both hyperkinetic movement disorders. Dystonia ar...
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) the...
Copyright © 2012 J. Guridi et al. This is an open access article distributed under the Creative Comm...
Panagiotis Bargiotas, Spyridon KonitsiotisDepartment of Neurology, University of Ioannina, Ioannina,...
The most commonly used treatment for Parkinson’s disease (PD) is levodopa, prescribed in conjunction...
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) the...
Parkinson‘s disease (PD) is a progressive and disabling neurodegenerative disease, characterized by ...
Levodopa-induced dyskinesias (LID) are common and difficult to treat. This review focuses on three i...
Levodopa remains the primary drug for controlling motor symptoms in Parkinson’s disease through the ...
"Levodopa-induced dyskinesias (LID) are commonly encountered in advanced Parkinson's disease (PD), a...
DOI
Add to ORKG